ISRCTN48334111已完成不适用
Randomised, Double-Blind, Placebo Controlled, Cross Over Trial of a Parenteral Modified Cobratoxin in Adrenomyeloneuropathy
ReceptoPharm Inc. (USA)0 个研究点目标入组 0 人开始时间: 2005年3月10日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Male or female age =18 years
- •2. Diagnosis of AMN either biochemically or genetically
- •3. Have some motor disability that affects their gait
- •4. Willing and able to provide written informed consent
- •5. Willing and able to comply with study procedures
排除标准
- •Not provided at time of registration.
研究者
相似试验
进行中（未招募）
不适用
CONCERTA Lab School StudyMedDRA version: 18.0Level: LLTClassification code 10003735Term: Attention deficit-hyperactivity disorderSystem Organ Class: 100000004873Attention Deficit Hyperactivity DisorderEUCTR2015-001042-28-Outside-EU/EEAOrtho-McNeil Janssen Scientific Affairs LLC89
进行中（未招募）
1 期
Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven®/Niastase®) in Acute Intracerebral HaemorrhageEUCTR2004-004202-24-GBovo Nordisk A/S
进行中（未招募）
不适用
Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven®/Niastase®) in Acute Intracerebral HaemorrhageAcute Intracerebral HaemorrhageMedDRA version: 7.1Level: LLTClassification code 10022753EUCTR2004-004202-24-BEovo Nordisk A/S474
进行中（未招募）
不适用
Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven®/Niastase®) in Acute Intracerebral HaemorrhageEUCTR2004-004202-24-SEovo Nordisk A/S816
进行中（未招募）
1 期
Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven®/Niastase®) in Acute Intracerebral HaemorrhageAcute Intracerebral HaemorrhageMedDRA version: 7.1Level: LLTClassification code 10022753EUCTR2004-004202-24-NOovo Nordisk A/S